Professor of Breast Pathology, Barts Health NHS Trust, and Head of the Breast Research Group in the Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, with a research focus on the role of the microenvironment in mediating progression of DCIS to invasive breast cancer.

Co-Principal Investigator (Co-PI) of the national Breast Cancer Now Biobank, which includes the Primary Breast Cell Bank, isolating cell populations from tissues for the research community.

Lead for Molecular Pathology within Genomics England during the 100,000 Genomes Project, then taking on the role of Cellular Pathology Lead for North Thames GLH.

She sits on many Genomic Medicine national committees representing pathology and contributing to discussions around improving sample handling and pathways for genomic testing.

Also Research Lead for the National Breast Pathology Co-Ordinating Committee and Editor-in-Chief of The Journal of Pathology.

A founder of the Patient Advocate Course VOICE (Link), which brings patients into discussions on medicine, management, and research.

Now part of the leadership team of PharosAI (Link), a £43 million programme to translate AI into the clinic.